NLRP5 Protein, Human (sf9)

NLRP5 is a key SCMC member that coordinates zygote progression by regulating the formation of F-actin CPL, ensuring symmetric division and spindle positioning. It directs cortical granule positioning, connects to the actin scaffold for granule localization, and contributes to actin clearance prior to oocyte exocytosis. NLRP5 Protein, Human (sf9) is the recombinant human-derived NLRP5 protein, expressed by sf9 insect cells , with tag free.

NLRP5, a vital component of the subcortical maternal complex (SCMC), plays a crucial role in facilitating the progression of zygotes beyond the initial embryonic cell divisions by regulating actin dynamics. Its involvement in the formation of F-actin cytoplasmic lattices (CPL) in oocytes is essential for ensuring the symmetric division of zygotes through the regulation of mitotic spindle formation and positioning. Additionally, NLRP5 is required for the localization of cortical granules to the oocyte cortex, achieved through its association with the cortical actin scaffold. Furthermore, it contributes to cortical actin clearance preceding oocyte exocytosis. NLRP5 is implicated in the regulation of post-fertilization Ca(2+) release and endoplasmic reticulum (ER) storage by influencing ER localization. Its potential involvement in the localization of mitochondria in oocytes and early embryos, independent of CPL formation, adds another layer to its multifaceted functions. Within the SCMC, NLRP5 interacts with other components such as OOEP, KHDC3, and TLE6, and may facilitate the translocation of these components between nuclear and cytoplasmic compartments. Additionally, NLRP5 interacts with PRKCE and TUBB3, highlighting its diverse molecular associations.

Human

Sf9 insect cells

Tag Free

P59047 (G227-N1200)

126206

Partial

GHGGDTWDYKSHVMTKFAEEEDVRRSFENTAADWPEMQTLAGAFDSDRWGFRPRTVVLHGKSGIGKSALARRIVLCWAQGGLYQGMFSYVFFLPVREMQRKKESSVTEFISREWPDSQAPVTEIMSRPERLLFIIDGFDDLGSVLNNDTKLCKDWAEKQPPFTLIRSLLRKVLLPESFLIVTVRDVGTEKLKSEVVSPRYLLVRGISGEQRIHLLLERGIGEHQKTQGLRAIMNNRELLDQCQVPAVGSLICVALQLQDVVGESVAPFNQTLTGLHAAFVFHQLTPRGVVRRCLNLEERVVLKRFCRMAVEGVWNRKSVFDGDDLMVQGLGESELRALFHMNILLPDSHCEEYYTFFHLSLQDFCAALYYVLEGLEIEPALCPLYVEKTKRSMELKQAGFHIHSLWMKRFLFGLVSEDVRRPLEVLLGCPVPLGVKQKLLHWVSLLGQQPNATTPGDTLDAFHCLFETQDKEFVRLALNSFQEVWLPINQNLDLIASSFCLQHCPYLRKIRVDVKGIFPRDESAEACPVVPLWMRDKTLIEEQWEDFCSMLGTHPHLRQLDLGSSILTERAMKTLCAKLRHPTCKIQTLMFRNAQITPGVQHLWRIVMANRNLRSLNLGGTHLKEEDVRMACEALKHPKCLLESLRLDCCGLTHACYLKISQILTTSPSLKSLSLAGNKVTDQGVMPLSDALRVSQCALQKLILEDCGITATGCQSLASALVSNRSLTHLCLSNNSLGNEGVNLLCRSMRLPHCSLQRLMLNQCHLDTAGCGFLALALMGNSWLTHLSLSMNPVEDNGVKLLCEVMREPSCHLQDLELVKCHLTAACCESLSCVISRSRHLKSLDLTDNALGDGGVAALCEGLKQKNSVLARLGLKACGLTSDCCEALSLALSCNRHLTSLNLVQNNFSPKGMMKLCSAFACPTSNLQIIGLWKWQYPVQIRKLLEEVQLLKPRVVIDGSWHSFDEDDRYWWKN

≥ 90%, as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.